so we have 484
125 around list in 100-500 price stock which is quite higher side
#MASTEK Update
— Gurleen (@GurleenKaur_19) July 23, 2021
2800 Hit; 70% Booked and rest Holding for a target of 2900.
#StockMarket #StockToWatch https://t.co/gQTyzf4IUS pic.twitter.com/fp9hrZyv7d
#CNBCTV18Exclusive | Catch @_anujsinghal, @_soniashenoy & @SurabhiUpadhyay in conversation with @HiralChandrana who was appointed as global CEO of #Mastek last month. He says that a big part of their strategy is to grow in the US. @Reematendulkar pic.twitter.com/nRnfGoGHTp
— CNBC-TV18 (@CNBCTV18News) August 18, 2021
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz